Anthem Vice President for Corporate Development Steve Schlegel said during a U.S. antitrust trial Wednesday that 23 percent of Cigna’s domestic revenue would have to be branded Blue to comply with association rules. BCBS association requires two-thirds of its products be Blue-branded, according to the report. However if the deal succeeds, the resulting company’s revenue would fall short of the requirement and the insurer would have 120 days to propose a compliance plan.
Anthem has said if it acquires Cigna, Anthem would maintain Cigna as a stand-alone company to compete with other BCBS subsidiaries beyond Anthem’s territories. Although branding Cigna products Blue in the 14 states where it has BCBS exclusivity would meet the requirement, Mr. Schlegel denied that was the plan, Bloomberg reports.
Indianapolis-based Anthem and Bloomfield, Conn.-based Cigna are defending their proposed $54 billion acquisition agreement in Washington, D.C., against a lawsuit filed July 21 by the Justice Department. The trial started Nov. 21 with DOJ arguments, and Anthem began its defense Tuesday.
More articles on payer issues:
Fitch issues negative outlook for health insurers due to leverage, exchange profitability concerns
ACA plan enrollment up 97k from last year
Anthem starts Cigna deal defense: 4 takeaways
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.